>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
外泌体在肺相关疾病中的诊治作用及其分子机制研究进展
作者:丁旭  张浩天  杨凯哲  王哲  张宇  成于思  巢杰 
单位:东南大学医学院 生理学系, 江苏 南京 210009
关键词:外泌体 肺部疾病 发病机制 诊断 治疗 综述 
分类号:R563
出版年·卷·期(页码):2022·41·第五期(725-730)
摘要:

外泌体是由细胞分泌释放到细胞外基质的纳米级膜性囊泡,其由脂质双层膜包裹。外泌体富含细胞特异的蛋白质、脂类以及核酸等多种生物活性物质,参与多种疾病的病理生理过程,可作为细胞间的重要信息载体,广泛参与细胞间的信息传递。近年来,越来越多的研究指出外泌体在一些肺部炎症性疾病的发病进展中发挥着重要作用,如急性呼吸窘迫综合征、支气管哮喘、慢性阻塞性肺疾病等,故外泌体有望作为这些疾病的新型诊断标志物及生物治疗靶点。本文作者综述了外泌体在肺相关疾病中作用的研究进展。

参考文献:

[1] LOBB R J, LIMA L G, MOLLER A.Exosomes:key mediators of metastasis and pre-metastatic niche formation[J].Semin Cell Dev Biol, 2017, 67:3-10.
[2] BARILE L, VASSALLI G.Exosomes:therapy delivery tools and biomarkers of diseases[J].Pharmacol Ther, 2017, 174:63-78.
[3] TAYLOR D D.Isolation, molecular characterization of extracellular vesicles[J].Methods, 2015, 87:1-2.
[4] HOUGH K P, CHANDA D, DUNCAN S R, et al.Exosomes in immunoreg ulation of chronic lung diseases[J].Allergy, 2017, 72(4):534-544.
[5] THOMPSON B T, CHAMBERS R C, LIU K D.Acute respiratory distress syndrome[J].N Engl J Med, 2017, 377(19):1904-1905.
[6] XU B, CHEN S S, LIU M Z, et al.Stem cell derived exosomes-based therapy for acute lung injury and acute respiratory distress syndrome:a novel therapeutic strategy[J].Life Sci, 2020, 254(6):117766.
[7] ZHU Y G, QU J M, ZHANG J, et al.Novel interventional approaches for ALI/ARDS:cell-based gene therapy[J].Mediators Inflamm, 2011, 2011:560194.
[8] EGEA-JIMENEZ A L, ZIMMERMANNP.Phospholipase D and phosphatidic acid in the biogenesis and cargo loading of extracellular vesicles[J].J Lipid Res, 2018, 59(9):1554-1560.
[9] YILMAZ G, VITAL S, YILMAZ C E, et al.Selectin-mediated recruitment of bone marrow stromal cells in the postischemic cerebral microvasculature[J].Stroke, 2011, 42(3):806-811.
[10] FANG X, NEYRINCK A P, MATTHAY M A, et al.Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1[J].J Biol Chem, 2010, 285(34):26211-26222.
[11] MONSEL A, ZHU Y G, GUDAPATI V, et al.Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases[J].Expert Opin Biol Ther, 2016, 16(7):859-871.
[12] FANG S, XU C, ZHANG Y, et al.Umbilical cord-derived mesenchymal stem cell-derived exosomal microRNAs suppress myofibroblast differentiation by inhibiting the transforming growth factor-beta/SMAD2 pathway during wound healing[J].Stem Cells Transl Med, 2016, 5(10):1425-1439.
[13] FUJITA Y, YOSHIOKA Y, ITO S, et al.Intercellular communication by extracellular vesicles and their microRNAs in asthma[J].Clin Ther, 2014, 36(6):873-881.
[14] MAZZEO C, CANAS J A, ZAFRA M P, et al.Exosome secretion by eosinophils:A possible role in asthma pathogenesis[J].J Allergy Clin Immunol, 2015, 135(6):1603-1613.
[15] TADOKORO T, WANG Y, BARAK L S, et al.IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells[J].Proc Natl Acad Sci U S A, 2014, 111(35):E3641-3649.
[16] KULSHRESHTHA A, AHMAD T, AGRAWAL A, et al.Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation[J].J Allergy Clin Immunol, 2013, 131(4):1194-203, 1203e1-14.
[17] CANAS J A, SASTRE B, RODRIGO-MUNOZ J M, et al.Exosomes:a new approach to asthma pathology[J].Clin Chim Acta, 2019, 495:139-147.
[18] DUY M, ZHUANSUN Y X, CHEN R, et al.Mesenchymal stem cell exosomes promote immunosuppression of regulatory T cells in asthma[J].Exp Cell Res, 2018, 363(1):114-120.
[19] WELTE T.Chronic obstructive pulmonary disease-a growing cause of death and disability worldwide[J].Dtsch Arztebl Int, 2014, 111(49):825-826.
[20] 徐冬川, 何蝉伊, 林琦, 等.CSE诱导支气管上皮细胞分泌外泌体miR-186促进肺成纤维细胞增殖[J].海南医学院学报, 2021, 27(11):814-819.
[21] 杨玥, 卞涛.不同细胞来源的外泌体在COPD中的研究进展[J].基础医学与临床, 2020, 40(12):1721-1726.
[22] 谢羽飞, 赵洁, 杨益秀, 等.miR-186在慢性阻塞性肺疾病患者血清外泌体中表达与临床意义[J].海南医学院学报, 2020, 26(24):1855-1858, 1864.
[23] 卢文静, 卢丽琨, 汪宇.外泌体与COPD[J].实用老年医学, 2021, 35(3):219-221.
[24] WANG L, CHEN Q, YU Q, et al.Cigarette smoke extract-treated airway epithelial cells-derived exosomes promote M1 macrophage polarization in chronic obstructive pulmonary disease[J].Int Immunopharmacol, 2021, 96:107700.
[25] 孙梦婷, 李慧芹, 谭滇湘, 等.外泌体在肺部炎症性疾病中的研究进展[J].实用预防医学, 2021, 28(1):124-129.
[26] KATZ-KIRIAKOS E, STEINBERG D F, KLUENDER C E, et al.Epithelial IL-33 appropriates exosome trafficking for secretion in chronic airway disease[J].JCI Isight, 2021, 6(4):e136166.
[27] CHIOMA O S, DRAKE W P.Role of microbial agents in pulmonary fibrosis[J].Yale J Biol Med, 2017, 90(2):219-227.
[28] LIANG H, LIU S, CHEN Y, et al.miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis:potential cross-talks among miRNAs in IPF[J].J Mol Med (Berl), 2016, 94(6):655-665.
[29] LIU B, JIANG T, HU X, et al.Downregulation of microRNA30a in bronch oalveolar lavage fluid from idiopathic pulmonary fibrosis patients[J].Mol Med Rep, 2018, 18(6):5799-5806.
[30] SUNG H, FERLAY J, SIEGEL R L, et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2021, 71(3):209-249.
[31] KUJTAN L, SUBRAMANIAN J.Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small cell lung cancer[J].Expert Rev Anticancer Ther, 2019, 19(7):547-559.
[32] CLARK D J, FONDRIE W E, YANG A, et al.Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes[J].J Proteomics, 2016, 133:161-169.
[33] SANDFELD-PAULSEN B, AGGERHOLM-PEDERSEN N, BAEK R, et al.Exosomal proteins as prognostic biomarkers in non-small cell lung cancer[J].Mol Oncol, 2016, 10(10):1595-1602.
[34] UEDA K, ISHIKAWA N, TATSUGUCHI A, et al.Antibody-coupled monolithic silica microtips for highthroughput molecular profiling of circulating exosomes[J].Sci Rep, 2014, 4:6232.
[35] QI Y, ZHA W, ZHANG W.Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer[J].J BUON, 2019, 24(2):599-607.
[36] KIM D H, PARK S, KIM H, et al.Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4[J].Cancer Lett, 2020, 475:2-13.
[37] GRIMOLIZZI F, MONACO F, LEONI F, et al.Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression[J].Sci Rep, 2017, 7(1):15277.
[38] ZHANG Y, YIN Y, LI S.Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients[J].Pathol Res Pract, 2019, 215(8):152466.
[39] XIAO X, YU S, LI S, et al.Exosomes:decreased sensitivity of lung cancer A549 cells to cisplatin[J].PLoS One, 2014, 9(2):e89534.
[40] LI H, ZHANG P, SUN X, et al.MicroRNA-181a regulates epithelial-mesenchymal transition by targeting PTEN in drug-resistant lung adenocarcinoma cells[J].Int J Oncol, 2015, 47(4):1379-1392.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414897 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364